Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Alberti, KGMM
   Treating type 2 diabetes - today's targets, tomorrow's goals
   DIABETES OBESITY & METABOLISM
   
   K.G.M.M. Alberti, "Treating type 2 diabetes - today's targets, tomorrow's goals", DIABET OB M, 3, 2001, pp. S3-S10
2. Scheen, AJ
   Thiazolidinediones and liver toxicity
   DIABETES & METABOLISM
   
   A.J. Scheen, "Thiazolidinediones and liver toxicity", DIABETE MET, 27(3), 2001, pp. 305-313
3. Brown, JB; Nichols, GA; Glauber, HS; Bakst, AW; Schaeffer, M; Kelleher, CC
   Health care costs associated with escalation of drug treatment in type 2 diabetes mellitus
   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
   
   J.B. Brown et al., "Health care costs associated with escalation of drug treatment in type 2 diabetes mellitus", AM J HEAL S, 58(2), 2001, pp. 151-157
4. Halas, CJ
   Nateglinide
   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
   
   C.J. Halas, "Nateglinide", AM J HEAL S, 58(13), 2001, pp. 1200-1205
5. Yu, EH; Guo, HR; Wu, TJ
   Factors associated with discontinuing insulin therapy after diabetic ketoacidosis in adult diabetic patients
   DIABETIC MEDICINE
   
   E.H. Yu et al., "Factors associated with discontinuing insulin therapy after diabetic ketoacidosis in adult diabetic patients", DIABET MED, 18(11), 2001, pp. 895-899
6. Malamas, MS; Sredy, J; McCaleb, M; Gunawan, I; Mihan, B; Sullivan, D
   Antihyperglycemic activity of new 1,2,4-oxadiazolidine-3,5-diones
   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
   
   M.S. Malamas et al., "Antihyperglycemic activity of new 1,2,4-oxadiazolidine-3,5-diones", EUR J MED C, 36(1), 2001, pp. 31-42
7. Holl, RW; Wabitsch, M; Heinze, E
   Type-2-diabetes in children and adolescents
   MONATSSCHRIFT KINDERHEILKUNDE
   
   R.W. Holl et al., "Type-2-diabetes in children and adolescents", MONATS KIND, 149(7), 2001, pp. 660-669
8. Culy, CR; Jarvis, B
   Repaglinide - A review of its therapeutic use in type 2 diabetes mellitus
   DRUGS
   
   C.R. Culy e B. Jarvis, "Repaglinide - A review of its therapeutic use in type 2 diabetes mellitus", DRUGS, 61(11), 2001, pp. 1625-1660
9. Arakawa, K; Ishihara, T; Oku, A; Nawano, M; Ueta, K; Kitamura, K; Matsumoto, M; Saito, A
   Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na+-glucose cotransporter inhibitor T-1095
   BRITISH JOURNAL OF PHARMACOLOGY
   
   K. Arakawa et al., "Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na+-glucose cotransporter inhibitor T-1095", BR J PHARM, 132(2), 2001, pp. 578-586
10. Bozdag-Dundar, O; Waheed, A; Verspohl, EJ; Ertan, R
    Synthesis and hypoglycemic activity of some new flavone derivatives - 4th Communication: 6-Flavonyl-2,4-thiazolidinediones
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    
    O. Bozdag-Dundar et al., "Synthesis and hypoglycemic activity of some new flavone derivatives - 4th Communication: 6-Flavonyl-2,4-thiazolidinediones", ARZNEI-FOR, 51(8), 2001, pp. 623-627
11. Kipnes, MS; Krosnick, A; Rendell, MS; Egan, JW; Mathisen, AL; Schneider, RL
    Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: A randomized, placebo-controlled study
    AMERICAN JOURNAL OF MEDICINE
    
    M.S. Kipnes et al., "Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: A randomized, placebo-controlled study", AM J MED, 111(1), 2001, pp. 10-17
12. Chu-Moyer, MY
    Patent focus on antidiabetic agents: September 1999-February 2000
    EXPERT OPINION ON THERAPEUTIC PATENTS
    
    M.Y. Chu-Moyer, "Patent focus on antidiabetic agents: September 1999-February 2000", EXPERT OP T, 10(6), 2000, pp. 787-801
13. Rami, HK; Smith, SA
    Synthetic ligands for PPAR gamma - review of patent literature 1994-1999
    EXPERT OPINION ON THERAPEUTIC PATENTS
    
    H.K. Rami e S.A. Smith, "Synthetic ligands for PPAR gamma - review of patent literature 1994-1999", EXPERT OP T, 10(5), 2000, pp. 623-634
14. Wood, HB; Black, R; Salituro, G; Szalkowski, D; Li, ZH; Zhang, Y; Moller, DE; Zhang, B; Jones, AB
    The basal SAR of a novel insulin receptor activator
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    
    H.B. Wood et al., "The basal SAR of a novel insulin receptor activator", BIOORG MED, 10(11), 2000, pp. 1189-1192
15. Hanefeld, M; Goke, B
    Combining pioglitazone with a sulphonylurea or metformin in the managementof type 2 diabetes
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    
    M. Hanefeld e B. Goke, "Combining pioglitazone with a sulphonylurea or metformin in the managementof type 2 diabetes", EXP CL E D, 108, 2000, pp. S256-S266
16. Berger, J; Patel, HV; Woods, J; Hayes, NS; Parent, SA; Clemas, J; Leibowitz, MD; Elbrecht, A; Rachubinski, RA; Capone, JP; Moller, DE
    A PPAR gamma mutant serves as a dominant negative inhibitor of PPAR signaling and is localized in the nucleus
    MOLECULAR AND CELLULAR ENDOCRINOLOGY
    
    J. Berger et al., "A PPAR gamma mutant serves as a dominant negative inhibitor of PPAR signaling and is localized in the nucleus", MOL C ENDOC, 162(1-2), 2000, pp. 57-67
17. Malamas, MS; Sredy, J; Gunawan, I; Mihan, B; Sawicki, DR; Seestaller, L; Sullivan, D; Flam, BR
    New azolidinediones as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties
    JOURNAL OF MEDICINAL CHEMISTRY
    
    M.S. Malamas et al., "New azolidinediones as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties", J MED CHEM, 43(5), 2000, pp. 995-1010
18. Chehade, JM; Mooradian, AD
    A rational approach to drug therapy of type 2 diabetes mellitus
    DRUGS
    
    J.M. Chehade e A.D. Mooradian, "A rational approach to drug therapy of type 2 diabetes mellitus", DRUGS, 60(1), 2000, pp. 95-113
19. Bozdag, O; Verspohl, EJ; Ertan, R
    Synthesis and hypoglycemic activity of some new flavone derivatives - 3rd communication: 3 '-flavonyl-2,4-thiazolidinediones
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    
    O. Bozdag et al., "Synthesis and hypoglycemic activity of some new flavone derivatives - 3rd communication: 3 '-flavonyl-2,4-thiazolidinediones", ARZNEI-FOR, 50(7), 2000, pp. 626-630
20. Bozdag, O; Verspohl, EJ; Ertan, R
    Synthesis and hypoglycemic activity of some new flavone derivatives - 2nd communication: 4 '-flavonyl-2,4-thiazolidinediones
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    
    O. Bozdag et al., "Synthesis and hypoglycemic activity of some new flavone derivatives - 2nd communication: 4 '-flavonyl-2,4-thiazolidinediones", ARZNEI-FOR, 50(6), 2000, pp. 539-543
21. Malaisse, WJ
    Physiology, pathology and pharmacology of insulin secretion
    ACTA CLINICA BELGICA
    
    W.J. Malaisse, "Physiology, pathology and pharmacology of insulin secretion", ACT CLIN B, 55(3), 2000, pp. 141-147
22. Shinkai, H
    Recent developments in oral hypoglycemic agents
    DRUG DISCOVERY TODAY
    
    H. Shinkai, "Recent developments in oral hypoglycemic agents", DRUG DISC T, 4(6), 1999, pp. 283-288
23. Ginsberg, H; Plutzky, J; Sobel, BE
    A review of metabolic and cardiovascular effects of oral antidiabetic agents: beyond glucose-level lowering
    JOURNAL OF CARDIOVASCULAR RISK
    
    H. Ginsberg et al., "A review of metabolic and cardiovascular effects of oral antidiabetic agents: beyond glucose-level lowering", J CARD RISK, 6(5), 1999, pp. 337-346
24. Kulkarni, SS; Gediya, LK; Kulkarni, VM
    Three-dimensional quantitative structure activity relationships (3-D-QSAR)of antihyperglycemic agents
    BIOORGANIC & MEDICINAL CHEMISTRY
    
    S.S. Kulkarni et al., "Three-dimensional quantitative structure activity relationships (3-D-QSAR)of antihyperglycemic agents", BIO MED CH, 7(7), 1999, pp. 1475-1485
25. Haigh, D; Allen, G; Birrell, HC; Buckle, DR; Cantello, BCC; Eggleston, DS; Haltiwanger, RC; Holder, JC; Lister, CA; Pinto, IL; Rami, HK; Sime, JT; Smith, SA; Sweeney, JD
    Non-thiazolidinedione antihyperglycaemic agents. Part 3: The effects of stereochemistry on the potency of alpha-methoxy-beta-phenylpropanoic acids
    BIOORGANIC & MEDICINAL CHEMISTRY
    
    D. Haigh et al., "Non-thiazolidinedione antihyperglycaemic agents. Part 3: The effects of stereochemistry on the potency of alpha-methoxy-beta-phenylpropanoic acids", BIO MED CH, 7(5), 1999, pp. 821-830
26. Gaupp, S; Effenberger, F
    Stereoselective follow-up reactions of (S)-2-sulfanyl nitriles
    TETRAHEDRON-ASYMMETRY
    
    S. Gaupp e F. Effenberger, "Stereoselective follow-up reactions of (S)-2-sulfanyl nitriles", TETRAHEDR-A, 10(9), 1999, pp. 1777-1786
27. Haigh, D; Birrell, HC; Cantello, BCC; Hindley, RM; Ramaswamy, A; Rami, HK; Stevens, NC
    Non-thiazolidinedione antihyperglycaemic agents. Part 4: Synthesis of ( plus /-)-, (R)-(+)- and (S)-(-)-enantiomers of 2-oxy-3-arylpropanoic acids
    TETRAHEDRON-ASYMMETRY
    
    D. Haigh et al., "Non-thiazolidinedione antihyperglycaemic agents. Part 4: Synthesis of ( plus /-)-, (R)-(+)- and (S)-(-)-enantiomers of 2-oxy-3-arylpropanoic acids", TETRAHEDR-A, 10(7), 1999, pp. 1335-1351
28. Haigh, D; Birrell, HC; Cantello, BCC; Eggleston, DS; Haltiwanger, RC; Hingley, RM; Ramaswamy, A; Stevens, NC
    Non-thiazolidinedione antihyperglycaemic agents. Part 5: Asymmetric aldol synthesis of (S)-(-)-2-oxy-3-arylpropanoic acids
    TETRAHEDRON-ASYMMETRY
    
    D. Haigh et al., "Non-thiazolidinedione antihyperglycaemic agents. Part 5: Asymmetric aldol synthesis of (S)-(-)-2-oxy-3-arylpropanoic acids", TETRAHEDR-A, 10(7), 1999, pp. 1353-1367
29. Malaisse, WJ
    Mechanism of action of a new class of insulin secretagogues
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    
    W.J. Malaisse, "Mechanism of action of a new class of insulin secretagogues", EXP CL E D, 107, 1999, pp. S140-S143
30. Davies, GF; Khandelwal, RL; Roesler, WJ
    Troglitazone inhibits expression of the phosphoenolpyruvate carboxykinase gene by an insulin-independent mechanism
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
    
    G.F. Davies et al., "Troglitazone inhibits expression of the phosphoenolpyruvate carboxykinase gene by an insulin-independent mechanism", BBA-MOL CEL, 1451(1), 1999, pp. 122-131
31. Emilien, G; Maloteaux, JM; Ponchon, M
    Pharmacological management of diabetes: Recent progress and future perspective in daily drug treatment
    PHARMACOLOGY & THERAPEUTICS
    
    G. Emilien et al., "Pharmacological management of diabetes: Recent progress and future perspective in daily drug treatment", PHARM THERA, 81(1), 1999, pp. 37-51
32. Howlett, HCS; Bailey, CJ
    A risk-benefit assessment of metformin in type 2 diabetes mellitus
    DRUG SAFETY
    
    H.C.S. Howlett e C.J. Bailey, "A risk-benefit assessment of metformin in type 2 diabetes mellitus", DRUG SAFETY, 20(6), 1999, pp. 489-503
33. Hongu, M; Saito, K; Tsujihara, K
    Solid-liquid phase transfer catalyzed novel glycosylation reaction of phenols
    SYNTHETIC COMMUNICATIONS
    
    M. Hongu et al., "Solid-liquid phase transfer catalyzed novel glycosylation reaction of phenols", SYN COMMUN, 29(16), 1999, pp. 2775-2781
34. Lohray, BB; Bhushan, V; Reddy, AS; Rao, PB; Reddy, NJ; Harikishore, P; Haritha, N; Vikramadityan, RK; Chakrabarti, R; Rajagopalan, R; Katneni, K
    Novel euglycemic and hypolipidemic agents. 4. Pyridyl- and quinolinyl-containing thiazolidinediones
    JOURNAL OF MEDICINAL CHEMISTRY
    
    B.B. Lohray et al., "Novel euglycemic and hypolipidemic agents. 4. Pyridyl- and quinolinyl-containing thiazolidinediones", J MED CHEM, 42(14), 1999, pp. 2569-2581
35. Reul, BA; Amin, SS; Buchet, JP; Ongemba, LN; Crans, DC; Brichard, SM
    Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats
    BRITISH JOURNAL OF PHARMACOLOGY
    
    B.A. Reul et al., "Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats", BR J PHARM, 126(2), 1999, pp. 467-477
36. Jajoo, HK; Mamidi, RNVS; Vakkalanka, SVS; Sathyavageeswaran, S; Katneni, K; Ayalasomayajula, PS; Rao, BP; Lohray, BB; Subramaniam, S
    Oral bioavailability and pharmacokinetics of the new insulin sensitizer DRF-2189 in Wistar rats
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    
    H.K. Jajoo et al., "Oral bioavailability and pharmacokinetics of the new insulin sensitizer DRF-2189 in Wistar rats", ARZNEI-FOR, 49(2), 1999, pp. 133-136
37. Osanai, H; Toki, Y; Nakashima, Y; Okumura, K; Ito, T; Hayakawa, T
    Reduction of vascular tone by introduction of troglitazone to the canine coronary artery
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    
    H. Osanai et al., "Reduction of vascular tone by introduction of troglitazone to the canine coronary artery", ARZNEI-FOR, 49(1), 1999, pp. 26-29
38. DeFronzo, RA
    Pharmacologic therapy for type 2 diabetes mellitus
    ANNALS OF INTERNAL MEDICINE
    
    R.A. DeFronzo, "Pharmacologic therapy for type 2 diabetes mellitus", ANN INT MED, 131(4), 1999, pp. 281-303
39. CHEN C
    TROGLITAZONE - AN ANTIDIABETIC AGENT (REPRINTED)
    American journal of health-system pharmacy
    
    C. Chen, "TROGLITAZONE - AN ANTIDIABETIC AGENT (REPRINTED)", American journal of health-system pharmacy, 55(9), 1998, pp. 905-925
40. REDDY KA; LOHRAY BB; BHUSHAN V; REDDY AS; KISHORE PH; RAO VV; SAIBABA V; BAJJI AC; RAJESH BM; REDDY KV; CHAKRABARTI R; RAJAGOPALAN R
    NOVEL EUGLYCEMIC AND HYPOLIPIDEMIC AGENTS - PART-2 - ANTIOXIDANT MOIETY AS STRUCTURAL MOTIF
    Bioorganic & medicinal chemistry letters
    
    K.A. Reddy et al., "NOVEL EUGLYCEMIC AND HYPOLIPIDEMIC AGENTS - PART-2 - ANTIOXIDANT MOIETY AS STRUCTURAL MOTIF", Bioorganic & medicinal chemistry letters, 8(9), 1998, pp. 999-1002
41. SAWICKI PT; BERGER M
    PHARMACOLOGICAL TREATMENT OF DIABETIC-PATIENTS WITH CARDIOVASCULAR COMPLICATIONS
    Journal of internal medicine
    
    P.T. Sawicki e M. Berger, "PHARMACOLOGICAL TREATMENT OF DIABETIC-PATIENTS WITH CARDIOVASCULAR COMPLICATIONS", Journal of internal medicine, 243(3), 1998, pp. 181-189
42. Pastore, L; Morviducci, L; Merante, D; Coppini, A; Mellozzi, M; D'Adamo, M; Sbraccia, P; Giaccari, A; Tamburrano, G
    Combined glibenclamide plus metformin improves insulin sensitivity in non-obese Type 2 diabetic patients
    DIABETES NUTRITION & METABOLISM
    
    L. Pastore et al., "Combined glibenclamide plus metformin improves insulin sensitivity in non-obese Type 2 diabetic patients", DIABET NUTR, 11(4), 1998, pp. 225-231
43. YOUNG PW; BUCKLE DR; CANTELLO BCC; CHAPMAN H; CLAPHAM JC; COYLE PJ; HAIGH D; HINDLEY RM; HOLDER JC; KALLENDER H; LATTER AJ; LAWRIE KWM; MOSSAKOWSKA D; MURPHY GJ; COX LR; SMITH SA
    IDENTIFICATION OF HIGH-AFFINITY BINDING-SITES FOR THE INSULIN SENSITIZER ROSIGLITAZONE (BRL-49653) IN RODENT AND HUMAN ADIPOCYTES USING A RADIOIODINATED LIGAND FOR PEROXISOMAL PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA
    The Journal of pharmacology and experimental therapeutics
    
    P.W. Young et al., "IDENTIFICATION OF HIGH-AFFINITY BINDING-SITES FOR THE INSULIN SENSITIZER ROSIGLITAZONE (BRL-49653) IN RODENT AND HUMAN ADIPOCYTES USING A RADIOIODINATED LIGAND FOR PEROXISOMAL PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA", The Journal of pharmacology and experimental therapeutics, 284(2), 1998, pp. 751-759
44. WROBEL J; LI ZN; DIETRICH A; MCCALEB M; MIHAN B; SREDY J; SULLIVAN D
    NOVEL -PROPYNYL)-5-(ARYLSULFONYL)THIAZOLIDINE-2,4-DIONES AS ANTIHYPERGLYCEMIC AGENTS
    Journal of medicinal chemistry
    
    J. Wrobel et al., "NOVEL -PROPYNYL)-5-(ARYLSULFONYL)THIAZOLIDINE-2,4-DIONES AS ANTIHYPERGLYCEMIC AGENTS", Journal of medicinal chemistry, 41(7), 1998, pp. 1084-1091
45. SHINKAI H; ONOGI S; TANAKA M; SHIBATA T; IWAO M; WAKITANI K; UCHIDA I
    ISOXAZOLIDINE-3,5-DIONE AND NONCYCLIC 1,3-DICARBONYL COMPOUNDS AS HYPOGLYCEMIC AGENTS
    Journal of medicinal chemistry
    
    H. Shinkai et al., "ISOXAZOLIDINE-3,5-DIONE AND NONCYCLIC 1,3-DICARBONYL COMPOUNDS AS HYPOGLYCEMIC AGENTS", Journal of medicinal chemistry, 41(11), 1998, pp. 1927-1933
46. LOHRAY BB; BHUSAN V; RAO BP; MEDHAVAN GR; MURALI N; RAO KN; REDDY AK; RAJESH BM; REDDY PG; CHAKRABARTI R; VIKRAMADITHYAN RK; RAJAGOPALAN R; MAMIDI RNVS; JAJOO HK; SUBRAMANIAN S
    NOVEL EUGLYCEMIC AND HYPOLIPIDEMIC AGENTS - 1
    Journal of medicinal chemistry
    
    B.B. Lohray et al., "NOVEL EUGLYCEMIC AND HYPOLIPIDEMIC AGENTS - 1", Journal of medicinal chemistry, 41(10), 1998, pp. 1619-1630
47. Henke, BR; Blanchard, SG; Brackeen, MF; Brown, KK; Cobb, JE; Collins, JL; Harrington, WW; Hashim, MA; Hull-Ryde, EA; Kaldor, I; Kliewer, SA; Lake, DH; Leesnitzer, LM; Lehmann, JM; Lenhard, JM; Orband-Miller, LA; Miller, JF; Mook, RA; Noble, SA; Oliver, W; Parks, DJ; Plunket, KD; Szewczyk, JR; Willson, TM
    N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents
    JOURNAL OF MEDICINAL CHEMISTRY
    
    B.R. Henke et al., "N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents", J MED CHEM, 41(25), 1998, pp. 5020-5036
48. Collins, JL; Blanchard, SG; Boswell, GE; Charifson, PS; Cobb, JE; Henke, BR; Hull-Ryde, EA; Kazmierski, WM; Lake, DH; Leesnitzer, LM; Lehmann, J; Lenhard, JM; Orband-Miller, LA; Gray-Nunez, Y; Parks, DJ; Plunkett, KD; Tong, WQ
    N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moiety
    JOURNAL OF MEDICINAL CHEMISTRY
    
    J.L. Collins et al., "N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moiety", J MED CHEM, 41(25), 1998, pp. 5037-5054
49. ARAKAWA K; ISHIHARA T; AOTO M; INAMASU M; SAITO A; IKEZAWA K
    ACTIONS OF NOVEL ANTIDIABETIC THIAZOLIDINEDIONE, T-174, IN ANIMAL-MODELS OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS (NIDDM) AND IN CULTUREDMUSCLE-CELLS
    British Journal of Pharmacology
    
    K. Arakawa et al., "ACTIONS OF NOVEL ANTIDIABETIC THIAZOLIDINEDIONE, T-174, IN ANIMAL-MODELS OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS (NIDDM) AND IN CULTUREDMUSCLE-CELLS", British Journal of Pharmacology, 125(3), 1998, pp. 429-436
50. UEDA N; NOMURA Y; MUTA Y; MATSUZAKI Y; HAYASHIBE M; INO Y; SUZUKI S; KURUMI M
    PHARMACOLOGICAL AND PHARMACOKINETIC STUDIES OF THE NEWLY SYNTHESIZED THIAZOLIDINEDIONE DERIVATIVE ROPANECARBONYLAMINO)BENZYL)-THIAZOLIDINE-2,4-DIONE
    Arzneimittel-Forschung
    
    N. Ueda et al., "PHARMACOLOGICAL AND PHARMACOKINETIC STUDIES OF THE NEWLY SYNTHESIZED THIAZOLIDINEDIONE DERIVATIVE ROPANECARBONYLAMINO)BENZYL)-THIAZOLIDINE-2,4-DIONE", Arzneimittel-Forschung, 48(6), 1998, pp. 651-657
51. HIRSCH IB
    APPROACH TO THE PATIENT WITH DIABETES UNDERGOING A VASCULAR OR INTERVENTIONAL PROCEDURE
    Journal of vascular and interventional radiology
    
    I.B. Hirsch, "APPROACH TO THE PATIENT WITH DIABETES UNDERGOING A VASCULAR OR INTERVENTIONAL PROCEDURE", Journal of vascular and interventional radiology, 8(3), 1997, pp. 329-336
52. LOHRAY BB; BHUSHAN V; RAO PB; MADHAVAN GR; MURALI N; RAO KN; REDDY KA; RAJESH BM; REDDY PG; CHAKRABARTI R; RAJAGOPALAN R
    NOVEL INDOLE CONTAINING THIAZOLIDINEDIONE DERIVATIVES AS POTENT EUGLYCEMIC AND HYPOLIPEMIC AGENTS
    Bioorganic & medicinal chemistry letters
    
    B.B. Lohray et al., "NOVEL INDOLE CONTAINING THIAZOLIDINEDIONE DERIVATIVES AS POTENT EUGLYCEMIC AND HYPOLIPEMIC AGENTS", Bioorganic & medicinal chemistry letters, 7(7), 1997, pp. 785-788
53. SILVA JE; RABELO R
    REGULATION OF THE UNCOUPLING PROTEIN GENE-EXPRESSION
    European journal of endocrinology
    
    J.E. Silva e R. Rabelo, "REGULATION OF THE UNCOUPLING PROTEIN GENE-EXPRESSION", European journal of endocrinology, 136(3), 1997, pp. 251-264
54. HUFF BE; LEFFELMAN CL; LETOURNEAU ME; SULLIVAN KA; WARD JA; STILLE JR
    SYNTHETIC APPROACHES TO BENZOFURAN CONTAINING INSULIN SENSITIVITY ENHANCER COMPOUNDS FOR TREATMENT OF TYPE-II DIABETES
    Heterocycles
    
    B.E. Huff et al., "SYNTHETIC APPROACHES TO BENZOFURAN CONTAINING INSULIN SENSITIVITY ENHANCER COMPOUNDS FOR TREATMENT OF TYPE-II DIABETES", Heterocycles, 45(7), 1997, pp. 1363-1384
55. YOSHIOKA T; FUJITA T
    STUDIES ON COMPOUNDS WITH ANTIOXIDANT ACTIVITY - DEVELOPMENT OF HYPOGLYCEMIC AGENTS, TROGLITAZONE (CS-045)
    Yakugaku zasshi
    
    T. Yoshioka e T. Fujita, "STUDIES ON COMPOUNDS WITH ANTIOXIDANT ACTIVITY - DEVELOPMENT OF HYPOGLYCEMIC AGENTS, TROGLITAZONE (CS-045)", Yakugaku zasshi, 117(9), 1997, pp. 597-610
56. IGARASHI M; TAKEDA Y; ISHIBASHI N; TAKAHASHI K; MORI S; TOMINAGA M; SAITO Y
    PIOGLITAZONE REDUCES SMOOTH-MUSCLE CELL-DENSITY OF RAT CAROTID ARTERIAL INTIMA INDUCED BY BALLOON CATHETERIZATION
    Hormone and Metabolic Research
    
    M. Igarashi et al., "PIOGLITAZONE REDUCES SMOOTH-MUSCLE CELL-DENSITY OF RAT CAROTID ARTERIAL INTIMA INDUCED BY BALLOON CATHETERIZATION", Hormone and Metabolic Research, 29(9), 1997, pp. 444-449
57. ARAKAWA K; INAMASU M; MATSUMOTO M; OKUMURA K; YASUDA K; AKATSUKA H; KAWANAMI S; WATANABE A; HOMMA K; SAIGA Y; OZEKI M; IIJIMA I
    NOVEL BENZOXAZOLE 2,4-THIAZOLIDINEDIONES AS POTENT HYPOGLYCEMIC AGENTS - SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS
    Chemical and Pharmaceutical Bulletin
    
    K. Arakawa et al., "NOVEL BENZOXAZOLE 2,4-THIAZOLIDINEDIONES AS POTENT HYPOGLYCEMIC AGENTS - SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS", Chemical and Pharmaceutical Bulletin, 45(12), 1997, pp. 1984-1993
58. MARK M; GRELL W
    HYPOGLYCEMIC EFFECTS OF THE NOVEL ANTIDIABETIC AGENT REPAGLINIDE IN RATS AND DOGS
    British Journal of Pharmacology
    
    M. Mark e W. Grell, "HYPOGLYCEMIC EFFECTS OF THE NOVEL ANTIDIABETIC AGENT REPAGLINIDE IN RATS AND DOGS", British Journal of Pharmacology, 121(8), 1997, pp. 1597-1604
59. KIYOTA Y; KONDO T; MAESHIBA Y; HASHIMOTO A; YAMASHITA KJ; YOSHIMURA Y; MOTOHASHI M; TANAYAMA S
    STUDIES ON THE METABOLISM OF THE NEW ANTIDIABETIC AGENT PIOGLITAZONE - IDENTIFICATION OF METABOLITES IN RATS AND DOGS
    Arzneimittel-Forschung
    
    Y. Kiyota et al., "STUDIES ON THE METABOLISM OF THE NEW ANTIDIABETIC AGENT PIOGLITAZONE - IDENTIFICATION OF METABOLITES IN RATS AND DOGS", Arzneimittel-Forschung, 47(1), 1997, pp. 22-28
60. BRESSLER R; JOHNSON DG
    PHARMACOLOGICAL REGULATION OF BLOOD-GLUCOSE LEVELS IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    Archives of internal medicine
    
    R. Bressler e D.G. Johnson, "PHARMACOLOGICAL REGULATION OF BLOOD-GLUCOSE LEVELS IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS", Archives of internal medicine, 157(8), 1997, pp. 836-848
61. YAMASHITA K; MURAKAMI H; OKUDA T; MOTOHASHI M
    HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF PIOGLITAZONEAND ITS METABOLITES IN HUMAN SERUM AND URINE
    Journal of chromatography B. Biomedical applications
    
    K. Yamashita et al., "HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF PIOGLITAZONEAND ITS METABOLITES IN HUMAN SERUM AND URINE", Journal of chromatography B. Biomedical applications, 677(1), 1996, pp. 141-146
62. TURNER NC
    NEW THERAPEUTIC AGENTS FOR THE TREATMENT OF INSULIN-RESISTANCE AND NIDDM
    Drug discovery today
    
    N.C. Turner, "NEW THERAPEUTIC AGENTS FOR THE TREATMENT OF INSULIN-RESISTANCE AND NIDDM", Drug discovery today, 1(3), 1996, pp. 109-116
63. LEMBERGER T; DESVERGNE B; WAHLI W
    PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS - A NUCLEAR RECEPTOR SIGNALING PATHWAY IN LIPID PHYSIOLOGY
    Annual review of cell and developmental biology
    
    T. Lemberger et al., "PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS - A NUCLEAR RECEPTOR SIGNALING PATHWAY IN LIPID PHYSIOLOGY", Annual review of cell and developmental biology, 12, 1996, pp. 335
64. MARTIN AE; MONTGOMERY PA
    ACARBOSE - AN ALPHA-GLUCOSIDASE INHIBITOR
    American journal of health-system pharmacy
    
    A.E. Martin e P.A. Montgomery, "ACARBOSE - AN ALPHA-GLUCOSIDASE INHIBITOR", American journal of health-system pharmacy, 53(19), 1996, pp. 2277-2290
65. BUCKLE DR; CANTELLO BCC; CAWTHORNE MA; COYLE PJ; DEAN DK; FALLER A; HAIGH D; HINDLEY RM; JEFCOTT LJ; LISTER CA; PINTO IL; RAMI HK; SMITH DG; SMITH SA
    NON THIAZOLIDINEDIONE ANTIHYPERGLYCEMIC AGENTS .1. ALPHA-HETEROATOM SUBSTITUTED BETA-PHENYLPROPANOIC ACIDS
    Bioorganic & medicinal chemistry letters
    
    D.R. Buckle et al., "NON THIAZOLIDINEDIONE ANTIHYPERGLYCEMIC AGENTS .1. ALPHA-HETEROATOM SUBSTITUTED BETA-PHENYLPROPANOIC ACIDS", Bioorganic & medicinal chemistry letters, 6(17), 1996, pp. 2121-2126
66. PEULER JD; PHARE SM; IANNUCCI AR; HODOREK MJ
    DIFFERENTIAL INHIBITORY EFFECTS OF ANTIDIABETIC DRUGS ON ARTERIAL SMOOTH-MUSCLE CELL-PROLIFERATION
    American journal of hypertension
    
    J.D. Peuler et al., "DIFFERENTIAL INHIBITORY EFFECTS OF ANTIDIABETIC DRUGS ON ARTERIAL SMOOTH-MUSCLE CELL-PROLIFERATION", American journal of hypertension, 9(2), 1996, pp. 188-192
67. MELANDER A
    ORAL ANTIDIABETIC DRUGS - AN OVERVIEW
    Diabetic medicine
    
    A. Melander, "ORAL ANTIDIABETIC DRUGS - AN OVERVIEW", Diabetic medicine, 13(9), 1996, pp. 143-147
68. PISU E; MARENA S; ARCARI R; MONTEGROSSO G; GRISERI P; DEMICHIELI F; PAGANO G
    DEPRESSED INSULIN-SECRETION IN RESPONSE TO DIFFERENT STIMULI IS A FEATURE OF SECONDARY FAILURE IN NORMAL-WEIGHT NON-INSULIN-DEPENDENT DIABETICS ON SULFONYLUREAS
    Diabetes, nutrition & metabolism
    
    E. Pisu et al., "DEPRESSED INSULIN-SECRETION IN RESPONSE TO DIFFERENT STIMULI IS A FEATURE OF SECONDARY FAILURE IN NORMAL-WEIGHT NON-INSULIN-DEPENDENT DIABETICS ON SULFONYLUREAS", Diabetes, nutrition & metabolism, 9(1), 1996, pp. 22-28
69. LAMBERTH C; BLARER S
    CONCISE APPROACH TO 1-THIAHYDANTOCIDIN
    Synthetic communications
    
    C. Lamberth e S. Blarer, "CONCISE APPROACH TO 1-THIAHYDANTOCIDIN", Synthetic communications, 26(1), 1996, pp. 75-81
70. HULIN B; NEWTON LS; LEWIS DM; GENEREUX PE; GIBBS EM; CLARK DA
    HYPOGLYCEMIC ACTIVITY OF A SERIES OF ALPHA-ALKYLTHIO AND ALPHA-ALKOXYCARBOXYLIC-ACIDS RELATED TO CIGLITAZONE
    Journal of medicinal chemistry
    
    B. Hulin et al., "HYPOGLYCEMIC ACTIVITY OF A SERIES OF ALPHA-ALKYLTHIO AND ALPHA-ALKOXYCARBOXYLIC-ACIDS RELATED TO CIGLITAZONE", Journal of medicinal chemistry, 39(20), 1996, pp. 3897-3907
71. JOHNSON RA; MARSHALL VP; LI GP; SIH JC; CIALDELLA JI; LIGGETT WF; NIDY EG
    MICROBIOLOGICAL N-DEOXYGENATION AND C-OXYGENATION OF PIOGLITAZONE-N-OXIDE IN A SINGLE FERMENTATION
    Journal of antibiotics
    
    R.A. Johnson et al., "MICROBIOLOGICAL N-DEOXYGENATION AND C-OXYGENATION OF PIOGLITAZONE-N-OXIDE IN A SINGLE FERMENTATION", Journal of antibiotics, 49(8), 1996, pp. 788-793
72. PEREZROLDAN F; AGUIRRE A; BANARES R; CASADO M; GONZALEZASANZA C; ALVAREZ E; CLEMENTE G
    CHOLESTATIC HEPATITIS INDUCED BY GLYBENCL AMIDE IN A PATIENT WITH HEPATITIS-C VIRUS
    Revista espanola de enfermedades digestivas
    
    F. Perezroldan et al., "CHOLESTATIC HEPATITIS INDUCED BY GLYBENCL AMIDE IN A PATIENT WITH HEPATITIS-C VIRUS", Revista espanola de enfermedades digestivas, 87(2), 1995, pp. 174-176
73. FORMAN BM; TONTONOZ P; CHEN J; BRUN RP; SPIEGELMAN BM; EVANS RM
    15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2) IS A LIGAND FOR THE ADIPOCYTE DETERMINATION FACTOR PPAR-GAMMA
    Cell
    
    B.M. Forman et al., "15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2) IS A LIGAND FOR THE ADIPOCYTE DETERMINATION FACTOR PPAR-GAMMA", Cell, 83(5), 1995, pp. 803-812
74. KEES KL; CAGGIANO TJ; STEINER KE; FITZGERALD JJ; KATES MJ; CHRISTOS TE; KULISHOFF JM; MOORE RD; MCCALEB ML
    STUDIES ON NEW ACIDIC AZOLES AS GLUCOSE-LOWERING AGENTS IN OBESE, DIABETIC DB DB MICE/
    Journal of medicinal chemistry
    
    K.L. Kees et al., "STUDIES ON NEW ACIDIC AZOLES AS GLUCOSE-LOWERING AGENTS IN OBESE, DIABETIC DB DB MICE/", Journal of medicinal chemistry, 38(4), 1995, pp. 617-628
75. HEITZMANN T; NEIDLEIN R; FREUND P; REIFF K; STREIN K
    DOSE PROPORTIONALITY STUDIES OF NOVEL THIAZOLIDINEDIONE DERIVATIVES AS POTENT ANTIDIABETIC AGENTS IN MICE
    Arzneimittel-Forschung
    
    T. Heitzmann et al., "DOSE PROPORTIONALITY STUDIES OF NOVEL THIAZOLIDINEDIONE DERIVATIVES AS POTENT ANTIDIABETIC AGENTS IN MICE", Arzneimittel-Forschung, 45-2(12), 1995, pp. 1284-1288
76. DENANTEUIL G; HERVE Y; DUHAULT J; ESPINAL J; BOULANGER M; RAVEL D
    EUGLYCEMIC AND BIOLOGICAL-ACTIVITIES OF NOVEL THIAZOLIDINE-2,4-DIONE DERIVATIVES
    Arzneimittel-Forschung
    
    G. Denanteuil et al., "EUGLYCEMIC AND BIOLOGICAL-ACTIVITIES OF NOVEL THIAZOLIDINE-2,4-DIONE DERIVATIVES", Arzneimittel-Forschung, 45-2(11), 1995, pp. 1176-1181
77. HEITZMANN T; NEIDLEIN R; FREUND P; REIFF K; STREIN K
    PHARMACOKINETICS OF SOME NEW ORAL BLOOD GLUCOSE-LOWERING AGENTS IN DOGS
    Arzneimittel-Forschung
    
    T. Heitzmann et al., "PHARMACOKINETICS OF SOME NEW ORAL BLOOD GLUCOSE-LOWERING AGENTS IN DOGS", Arzneimittel-Forschung, 45-2(11), 1995, pp. 1182-1187
78. CANTELLO BCC; CAWTHORNE MA; HAIGH D; HINDLEY RM; SMITH SA; THURLBY PL
    THE SYNTHESIS OF BRL-49653 - A NOVEL AND POTENT ANTIHYPERGLYCEMIC AGENT
    Bioorganic & medicinal chemistry letters
    
    B.C.C. Cantello et al., "THE SYNTHESIS OF BRL-49653 - A NOVEL AND POTENT ANTIHYPERGLYCEMIC AGENT", Bioorganic & medicinal chemistry letters, 4(10), 1994, pp. 1181-1184
79. CANTELLO BCC; CAWTHORNE MA; COTTAM GP; DUFF PT; HAIGH D; KINDLEY RM; LISTER CA; SMITH SA; THURLBY PL
    OCYCLYLAMINO)ALKOXY]BENZYL]-2,4-THIAZOLIDINEDIONES AS POTENT ANTIHYPERGLYCEMIC AGENTS
    Journal of medicinal chemistry
    
    B.C.C. Cantello et al., "OCYCLYLAMINO)ALKOXY]BENZYL]-2,4-THIAZOLIDINEDIONES AS POTENT ANTIHYPERGLYCEMIC AGENTS", Journal of medicinal chemistry, 37(23), 1994, pp. 3977-3985
80. YAMAGUCHI T; MIURA K; USUI T; UNNO R; MATSUMOTO Y; FUKUSHIMA M; MIZUNO K; KONDO Y; BABA Y; KURONO M
    SYNTHESIS AND ALDOSE REDUCTASE INHIBITORY ACTIVITY OF O[4H-1-BENZOPYRAN-4,4'-IMIDAZOLIDINE]-2',5'-DIONES
    Arzneimittel-Forschung
    
    T. Yamaguchi et al., "SYNTHESIS AND ALDOSE REDUCTASE INHIBITORY ACTIVITY OF O[4H-1-BENZOPYRAN-4,4'-IMIDAZOLIDINE]-2',5'-DIONES", Arzneimittel-Forschung, 44-1(3), 1994, pp. 344-348
81. SCHEEN AJ; LEFEBVRE PJ
    PHARMACOLOGICAL TREATMENT OF THE OBESE-DIABETIC PATIENT
    Diabete et metabolisme
    
    A.J. Scheen e P.J. Lefebvre, "PHARMACOLOGICAL TREATMENT OF THE OBESE-DIABETIC PATIENT", Diabete et metabolisme, 19(6), 1993, pp. 547-559
82. ELLINGBOE JW; LOMBARDO LJ; ALESSI TR; NGUYEN TT; GUZZO F; GUINOSSO CJ; BULLINGTON J; BROWNE ENC; BAGLI JF; WRENN J; STEINER K; MCCALEB ML
    ANTIHYPERGLYCEMIC ACTIVITY OF NOVEL NAPHTHALENYL 3H-1,2,3,5-OXATHIADIAZOLE 2-OXIDES
    Journal of medicinal chemistry
    
    J.W. Ellingboe et al., "ANTIHYPERGLYCEMIC ACTIVITY OF NOVEL NAPHTHALENYL 3H-1,2,3,5-OXATHIADIAZOLE 2-OXIDES", Journal of medicinal chemistry, 36(17), 1993, pp. 2485-2493
83. GOLDSTEIN SW; MCDERMOTT RE; GIBBS EM; STEVENSON RW
    HYDROXYUREA DERIVATIVES AS HYPOGLYCEMIC AGENTS
    Journal of medicinal chemistry
    
    S.W. Goldstein et al., "HYDROXYUREA DERIVATIVES AS HYPOGLYCEMIC AGENTS", Journal of medicinal chemistry, 36(15), 1993, pp. 2238-2240